FDA granted 510(k) clearance for combined technologies for Solventum.
1 report, 1 independent
Updated Oct 19
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
FDA granted 510(k) clearance for combined technologies for Solventum.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- FDA granted 510(k) clearance for a new panel developed by Hoffmann-La Roche.
- FDA approved combination clearances for Elanco's Experior use on June 27, 2025.
- FDA approval is the goal for product candidates from Daré Bioscience, Inc.
- Vivos is advancing its product line by securing patents via USPTO filings and gaining unprecedented 510K clearances for an alternative to CPAP technology.
- FDA placed a clinical hold on the drug application submitted by Bright Minds Biosciences Inc.